Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 7, 2002

View Archived Issues

Effective neuroprotection provided by new redox metabolic modulator

Neuroprotective estrogen analogue lacking hormonal effects characterized at Stroke conference

Cytokine-based gene therapy of brain ischemia promising according to Japanese research

Experiments link aromatase to neuroprotection in cerebral ischemia

Sildenafil demonstrates beneficial activity in rat model of cerebral ischemia

Glyceryl trinitrate reduces hypertension in stroke patients

Study finds oral contraceptives double the risk of first ischemic stroke

MEK1/2 inhibitor provides neuroprotection in cerebral ischemic injury

Xopenex approved for pediatric use in bronchospasm

Neurocrine updates clinical program progress in 2001

Gilead announces 2001 product highlights

Chlorambucil in the treatment of sight-threatening ocular inflammation

MCA approves phase II study of TTS in pancreatic cancer

CT-2106 cleared to enter phase I clinical testing

Encouraging results observed in phase IIa trial of AOD-9604 in obese patients

Novel dual gene therapy as a treatment for heart disease

Idun selects lead candidate for cardiovascular program

Sakai to codevelop and market Theratechnologies' ThGRF peptide in Japan

Amidine derivatives synthesized for neurological and neurodegenerative disorders

Takeda describes compounds for hyperlipidemia in recent patent

Merck discloses preparation and use of pyridine derivatives in CNS disorders

Nociceptin antagonists in the Banyu pipeline

New series from Taisho inhibits 20-HETE production

Acetylcholinesterase inhibitors described by Eisai for cognition disorders

Vitamin D analogues for the treatment of dermatoses

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...